Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Ractigen Therapeutics a leader in the development of small activating RNA therapeutics announced today that the US Food and Drug Administration has approved the companys Investigational New Drug
HUTCHMED today announces that its partner Takeda received notification that the Committee for Medicinal Products for Human Use of the European Medicines Agency
ENA Respiratory a clinicalstage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in atrisk populations announces
Sino Biological Inc a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents and related technical contract research services
PRISM BioLab Co Ltd a leading discovery and development biotechnology company designing small molecule inhibitors of proteinprotein interaction targets today announced that it has entered into a targetexclusive research and licensing agreement with O...
Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that its selective cathepsin K inhibitor MIV has been granted
Our customers depend on the high performance and reliability of the plates used in their highthroughput processes However increased throughput results in a higher carbon footprint
Cullinan Therapeutics Inc a biopharmaceutical company focused on modalityagnostic targeted therapies today announced that clinical data from its Phase trial of CLN in patients with advanced solid tumors
Atom Bioscience a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases has begun enrolling patients
Alkermes plc today announced initiation of the Vibrance study a phase clinical trial evaluating the safety and efficacy of ALKS compared to placebo in patients with narcolepsy type ALKS is the companys novel
